Search research articles
Contact Us
Filters
Showing results (21-30 of 121) with videos related to
Page
of 13
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 28, 2017
Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians
Bobby Shayegan, Frédéric Pouliot, Alan So, et al.
Nature Reviews. Urology
|
March 13, 2014
Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer
Homayoun Zargar, Jonathan Aning, Joseph Ischia, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo
Alan So, Shannon Sinnemann, David Huntsman, et al.
Current Drug Targets
|
October 22, 2013
Hsp27 as a therapeutic target in cancers
Julie Acunzo, Claudia Andrieu, Virginie Baylot, et al.
Molecular Cancer Therapeutics
|
January 16, 2007
Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells
Masayuki Kamada, Alan So, Mototsugu Muramaki, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 23, 2009
The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
Larry Goldenberg, Alan So, Neil Fleshner, et al.
Cancer Research
|
March 5, 2004
Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress
Ioannis P Trougakos, Alan So, Burkhard Jansen, et al.
The Journal of Urology
|
May 6, 2004
Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells
Hideaki Miyake, Hiroshi Eto, Isao Hara, et al.
BJU International
|
November 17, 2007
Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective
B Joyce Davison, Alan So, S Larry Goldenberg, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 18, 2018
Aquablation among novice users in Canada: A WATER II subpopulation analysis
Kevin C Zorn, S Larry Goldenberg, Ryan Paterson, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 121) with videos related to
Sort By:
Page
of 13
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 28, 2017
Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians
Bobby Shayegan, Frédéric Pouliot, Alan So, et al.
Nature Reviews. Urology
|
March 13, 2014
Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer
Homayoun Zargar, Jonathan Aning, Joseph Ischia, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo
Alan So, Shannon Sinnemann, David Huntsman, et al.
Current Drug Targets
|
October 22, 2013
Hsp27 as a therapeutic target in cancers
Julie Acunzo, Claudia Andrieu, Virginie Baylot, et al.
Molecular Cancer Therapeutics
|
January 16, 2007
Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells
Masayuki Kamada, Alan So, Mototsugu Muramaki, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 23, 2009
The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
Larry Goldenberg, Alan So, Neil Fleshner, et al.
Cancer Research
|
March 5, 2004
Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress
Ioannis P Trougakos, Alan So, Burkhard Jansen, et al.
The Journal of Urology
|
May 6, 2004
Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells
Hideaki Miyake, Hiroshi Eto, Isao Hara, et al.
BJU International
|
November 17, 2007
Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective
B Joyce Davison, Alan So, S Larry Goldenberg, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 18, 2018
Aquablation among novice users in Canada: A WATER II subpopulation analysis
Kevin C Zorn, S Larry Goldenberg, Ryan Paterson, et al.
Page
of 13